Charting a course for global progress in PIDs by 2030 - proceedings from the IPOPI global multi-stakeholders' summit (September 2023).

Front Immunol · 2024 · PMC11270239 · PMID 39055704

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Similarly, despite an increasing trend over time, only a minority of clinical trials and real-world evidence studies include PROMs as primary or secondary endpoints ( 91 , 92 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.